Last $37.25 USD
Change Today +0.70 / 1.92%
Volume 244.7K
GHDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dean L. Schorno

Chief Financial Officer and Principal Accounting Officer, Genomic Health Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$1,063,734
As of Fiscal Year 2012

Background*

Mr. Dean L. Schorno has been the Chief Financial Officer and Principal Accounting Officer at Genomic Health Inc. since January 3, 2011. Mr. Schorno served as Senior Vice President of Finance at Genomic Health Inc. from February 2010 to January 3, 2011 and also served as its Vice President of Finance from August 2008 to February 2010 and Vice President of Operations from January 2004 to August 2008. From July 2001 to December 2003, he led Genomic Health Inc.’s finance ...

Read Full Background

Corporate Headquarters*

301 Penobscot Drive
Redwood City, California 94063-4700

United States

Phone: 650-556-9300
Fax: 650-556-1132

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BSBA
University of California

Other Affiliations*

Annual Compensation*

Salary$340,000
Total Annual Compensation$340,000

Stock Options*

Restricted Stock Awards$115,880
Exercised Options9,000
Exercised Options Value$183,846
Exercisable Options81,145
Unexercisable Options60,480
Total Value of Options$183,846
Total Number of Options150,625

Total Compensation*

Total Annual Cash Compensation$446,100
Total Short Term Compensation$340,000
Other Long Term Compensation$115,880
Total Calculated Compensation$1,063,734
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GHDX:US $37.25 USD +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$445.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$613.0K
Richard O. Brajer Chief Executive Officer, President and Director
LipoScience, Inc.
$455.1K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMIC HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.